What are your thoughts on telitacicept use in SLE, and why has it not garnered more attention in US news cycle in rheumatology?

Telitacicept (a fully human TACI-Fc fusion protein that targets B lymphocyte stimulator (BLyS) and a proliferating-inducing ligand (APRIL) blocks the interaction of BLyS and APRIL, resulting in reduced B-cell proliferation and maturation. Theoretically, it makes sense that it should work in B-cell-d...

Timely question, as we just reviewed this paper in our journal club. I agree with @Dr. First Last that these are impressive results and certainly not what we typically observe in lupus trials. The placebo response is consistent with prior SLE studies, but the intervention arm response of 67% produce...